This site is intended for healthcare professionals
Latest drug news
  • Home
  • /
  • News
  • /
  • 2015
  • /
  • 09
  • /
  • Study of Linx Reflux Management System demonstrate...
Drug news

Study of Linx Reflux Management System demonstrates benefits in GERD- Torax Medical

Read time: 1 mins
Last updated:15th Sep 2015
Published:15th Sep 2015
Source: Pharmawand

Torax Medical announced completion of a landmark study confirming the long-term results of the Linx Reflux Management System in controlling reflux-related symptoms and eliminating dependence on acid suppression medications called proton pump inhibitors (PPIs) in patients with gastro-esophageal reflux disease (GERD). Findings from the clinical study demonstrated that the Linx procedure normalized the amount of acid in the esophagus, while safely and effectively relieving heartburn and regurgitation, and improving quality of life without the need for PPIs.

The Linx device was approved by the FDA in early 2012 and is currently the only medical device approved by the FDA to be safe and effective for the treatment of GERD. Authors of the clinical study, published this week in a leading medical journal; Clinical Gastroenterology and Hepatology concluded LINX should now be considered a first-line anti-reflux therapy for appropriate patients.

See: Long-Term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.